eNews
Home page > Comments


Comments

Japan approves Novo's new combination insulin Ryzodeg

26.12.2012. | COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday Japan's health regulator had approved its new combination insulin, that it plans to market as Ryzodeg, for the treatment of diabetes....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: